Therapeutic donor insemination: the impact of insemination timing with the aid of a urinary luteinizing hormone immunoassay
The records of 120 patients undergoing therapeutic donor insemination were reviewed to determine if the use of the enzyme immunoassay of urinary luteinizing hormone (LH) to plan inseminations decreased the number of cycles required to achieve conception. All inseminations were performed with fresh s...
Gespeichert in:
Veröffentlicht in: | Fertility and sterility 1988-06, Vol.49 (6), p.1026-1029 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1029 |
---|---|
container_issue | 6 |
container_start_page | 1026 |
container_title | Fertility and sterility |
container_volume | 49 |
creator | Kossoy, Liliana R. Hill, George A. Herbert, Carl M. Brodie, Beverly L. Dalglish, Carol S. Dupont, William D. Wentz, Anne Colston |
description | The records of 120 patients undergoing therapeutic donor insemination were reviewed to determine if the use of the enzyme immunoassay of urinary luteinizing hormone (LH) to plan inseminations decreased the number of cycles required to achieve conception. All inseminations were performed with fresh semen. Patients in group 1 (n=26) utilized urinary LH testing in addition to basal body temperature (BBT) and cervical mucus examinations to time their inseminations, while inseminations in group 2 (n=94) were timed with only BBT and cervical mucus examinations. The monthly fecundability of patients in group 1 was 0.13, whereas the monthly fecundability of patients in group 2 was 0.11. The mean number of inseminations was 1.4 and 1.6 per cycle for groups 1 and 2, respectively. There were no significant differences between groups 1 and 2 in regard to the number of cycles required to achieve conception. The use of a urinary LH immunoassay for insemination timing offers no benefit over conventional methods of timing (BBT, cervical mucus) when fresh donor semen is used. |
doi_str_mv | 10.1016/S0015-0282(16)59955-5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78237440</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0015028216599555</els_id><sourcerecordid>78237440</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-35b6162f443c7b40d2662415db94c23ce887fcb552a44f367568074435ce66dc3</originalsourceid><addsrcrecordid>eNqF0E2LFDEQBuAgyjqu_oSFPojooTUfXdU9XkQWv2DBg-s5pNPVTqQ7GZO0svrnTc8MA548JaGeqiQvY1eCvxRc4KsvnAuouezkc4EvYLsFqOEe2wgArAFB3WebM3nIHqX0nXOOopUX7ELJDmXXbdif2x1Fs6clO1sNwYdYOZ9odt5kF_zrKu-ocvPe2FyF8Z9alV3Zfqt-ubw7MOOG1ZhqiYXEu2paMjnvfq9qF-Ic_DprXnwwKZm7x-zBaKZET07rJfv6_t3t9cf65vOHT9dvb2rbKMy1gh4FyrFplG37hg8SUTYChn7bWKksdV072h5AmqYZFbaAHW-LBkuIg1WX7Nlx7j6GHwulrGeXLE2T8RSWpNtOquJ5gXCENoaUIo16H91cfqIF12vo-hC6XhPV5XQIXUPpuzpdsPQzDeeuU8ql_vRUN8maaYzGW5fOrBWIsMXC3hwZlTB-Ooo6WUfe0uAi2ayH4P7zkL9juJ-8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78237440</pqid></control><display><type>article</type><title>Therapeutic donor insemination: the impact of insemination timing with the aid of a urinary luteinizing hormone immunoassay</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Kossoy, Liliana R. ; Hill, George A. ; Herbert, Carl M. ; Brodie, Beverly L. ; Dalglish, Carol S. ; Dupont, William D. ; Wentz, Anne Colston</creator><creatorcontrib>Kossoy, Liliana R. ; Hill, George A. ; Herbert, Carl M. ; Brodie, Beverly L. ; Dalglish, Carol S. ; Dupont, William D. ; Wentz, Anne Colston</creatorcontrib><description>The records of 120 patients undergoing therapeutic donor insemination were reviewed to determine if the use of the enzyme immunoassay of urinary luteinizing hormone (LH) to plan inseminations decreased the number of cycles required to achieve conception. All inseminations were performed with fresh semen. Patients in group 1 (n=26) utilized urinary LH testing in addition to basal body temperature (BBT) and cervical mucus examinations to time their inseminations, while inseminations in group 2 (n=94) were timed with only BBT and cervical mucus examinations. The monthly fecundability of patients in group 1 was 0.13, whereas the monthly fecundability of patients in group 2 was 0.11. The mean number of inseminations was 1.4 and 1.6 per cycle for groups 1 and 2, respectively. There were no significant differences between groups 1 and 2 in regard to the number of cycles required to achieve conception. The use of a urinary LH immunoassay for insemination timing offers no benefit over conventional methods of timing (BBT, cervical mucus) when fresh donor semen is used.</description><identifier>ISSN: 0015-0282</identifier><identifier>EISSN: 1556-5653</identifier><identifier>DOI: 10.1016/S0015-0282(16)59955-5</identifier><identifier>PMID: 3286288</identifier><identifier>CODEN: FESTAS</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adult ; Biological and medical sciences ; Birth control ; Body Temperature ; Cervix Mucus - analysis ; Female ; Fertility ; Gynecology. Andrology. Obstetrics ; Humans ; Immunoenzyme Techniques ; Insemination, Artificial ; Insemination, Artificial, Heterologous ; Luteinizing Hormone - urine ; Male ; Medical sciences ; Menstrual Cycle ; Ovulation Detection - instrumentation ; Ovulation Detection - methods ; Sterility. Assisted procreation ; Time Factors</subject><ispartof>Fertility and sterility, 1988-06, Vol.49 (6), p.1026-1029</ispartof><rights>1988 American Society for Reproductive Medicine</rights><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-35b6162f443c7b40d2662415db94c23ce887fcb552a44f367568074435ce66dc3</citedby><cites>FETCH-LOGICAL-c436t-35b6162f443c7b40d2662415db94c23ce887fcb552a44f367568074435ce66dc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0015-0282(16)59955-5$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>309,310,314,780,784,789,790,3550,23930,23931,25140,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=7166596$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3286288$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kossoy, Liliana R.</creatorcontrib><creatorcontrib>Hill, George A.</creatorcontrib><creatorcontrib>Herbert, Carl M.</creatorcontrib><creatorcontrib>Brodie, Beverly L.</creatorcontrib><creatorcontrib>Dalglish, Carol S.</creatorcontrib><creatorcontrib>Dupont, William D.</creatorcontrib><creatorcontrib>Wentz, Anne Colston</creatorcontrib><title>Therapeutic donor insemination: the impact of insemination timing with the aid of a urinary luteinizing hormone immunoassay</title><title>Fertility and sterility</title><addtitle>Fertil Steril</addtitle><description>The records of 120 patients undergoing therapeutic donor insemination were reviewed to determine if the use of the enzyme immunoassay of urinary luteinizing hormone (LH) to plan inseminations decreased the number of cycles required to achieve conception. All inseminations were performed with fresh semen. Patients in group 1 (n=26) utilized urinary LH testing in addition to basal body temperature (BBT) and cervical mucus examinations to time their inseminations, while inseminations in group 2 (n=94) were timed with only BBT and cervical mucus examinations. The monthly fecundability of patients in group 1 was 0.13, whereas the monthly fecundability of patients in group 2 was 0.11. The mean number of inseminations was 1.4 and 1.6 per cycle for groups 1 and 2, respectively. There were no significant differences between groups 1 and 2 in regard to the number of cycles required to achieve conception. The use of a urinary LH immunoassay for insemination timing offers no benefit over conventional methods of timing (BBT, cervical mucus) when fresh donor semen is used.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Birth control</subject><subject>Body Temperature</subject><subject>Cervix Mucus - analysis</subject><subject>Female</subject><subject>Fertility</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Immunoenzyme Techniques</subject><subject>Insemination, Artificial</subject><subject>Insemination, Artificial, Heterologous</subject><subject>Luteinizing Hormone - urine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Menstrual Cycle</subject><subject>Ovulation Detection - instrumentation</subject><subject>Ovulation Detection - methods</subject><subject>Sterility. Assisted procreation</subject><subject>Time Factors</subject><issn>0015-0282</issn><issn>1556-5653</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0E2LFDEQBuAgyjqu_oSFPojooTUfXdU9XkQWv2DBg-s5pNPVTqQ7GZO0svrnTc8MA548JaGeqiQvY1eCvxRc4KsvnAuouezkc4EvYLsFqOEe2wgArAFB3WebM3nIHqX0nXOOopUX7ELJDmXXbdif2x1Fs6clO1sNwYdYOZ9odt5kF_zrKu-ocvPe2FyF8Z9alV3Zfqt-ubw7MOOG1ZhqiYXEu2paMjnvfq9qF-Ic_DprXnwwKZm7x-zBaKZET07rJfv6_t3t9cf65vOHT9dvb2rbKMy1gh4FyrFplG37hg8SUTYChn7bWKksdV072h5AmqYZFbaAHW-LBkuIg1WX7Nlx7j6GHwulrGeXLE2T8RSWpNtOquJ5gXCENoaUIo16H91cfqIF12vo-hC6XhPV5XQIXUPpuzpdsPQzDeeuU8ql_vRUN8maaYzGW5fOrBWIsMXC3hwZlTB-Ooo6WUfe0uAi2ayH4P7zkL9juJ-8</recordid><startdate>19880601</startdate><enddate>19880601</enddate><creator>Kossoy, Liliana R.</creator><creator>Hill, George A.</creator><creator>Herbert, Carl M.</creator><creator>Brodie, Beverly L.</creator><creator>Dalglish, Carol S.</creator><creator>Dupont, William D.</creator><creator>Wentz, Anne Colston</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19880601</creationdate><title>Therapeutic donor insemination: the impact of insemination timing with the aid of a urinary luteinizing hormone immunoassay</title><author>Kossoy, Liliana R. ; Hill, George A. ; Herbert, Carl M. ; Brodie, Beverly L. ; Dalglish, Carol S. ; Dupont, William D. ; Wentz, Anne Colston</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-35b6162f443c7b40d2662415db94c23ce887fcb552a44f367568074435ce66dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Birth control</topic><topic>Body Temperature</topic><topic>Cervix Mucus - analysis</topic><topic>Female</topic><topic>Fertility</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Immunoenzyme Techniques</topic><topic>Insemination, Artificial</topic><topic>Insemination, Artificial, Heterologous</topic><topic>Luteinizing Hormone - urine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Menstrual Cycle</topic><topic>Ovulation Detection - instrumentation</topic><topic>Ovulation Detection - methods</topic><topic>Sterility. Assisted procreation</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kossoy, Liliana R.</creatorcontrib><creatorcontrib>Hill, George A.</creatorcontrib><creatorcontrib>Herbert, Carl M.</creatorcontrib><creatorcontrib>Brodie, Beverly L.</creatorcontrib><creatorcontrib>Dalglish, Carol S.</creatorcontrib><creatorcontrib>Dupont, William D.</creatorcontrib><creatorcontrib>Wentz, Anne Colston</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Fertility and sterility</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kossoy, Liliana R.</au><au>Hill, George A.</au><au>Herbert, Carl M.</au><au>Brodie, Beverly L.</au><au>Dalglish, Carol S.</au><au>Dupont, William D.</au><au>Wentz, Anne Colston</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic donor insemination: the impact of insemination timing with the aid of a urinary luteinizing hormone immunoassay</atitle><jtitle>Fertility and sterility</jtitle><addtitle>Fertil Steril</addtitle><date>1988-06-01</date><risdate>1988</risdate><volume>49</volume><issue>6</issue><spage>1026</spage><epage>1029</epage><pages>1026-1029</pages><issn>0015-0282</issn><eissn>1556-5653</eissn><coden>FESTAS</coden><abstract>The records of 120 patients undergoing therapeutic donor insemination were reviewed to determine if the use of the enzyme immunoassay of urinary luteinizing hormone (LH) to plan inseminations decreased the number of cycles required to achieve conception. All inseminations were performed with fresh semen. Patients in group 1 (n=26) utilized urinary LH testing in addition to basal body temperature (BBT) and cervical mucus examinations to time their inseminations, while inseminations in group 2 (n=94) were timed with only BBT and cervical mucus examinations. The monthly fecundability of patients in group 1 was 0.13, whereas the monthly fecundability of patients in group 2 was 0.11. The mean number of inseminations was 1.4 and 1.6 per cycle for groups 1 and 2, respectively. There were no significant differences between groups 1 and 2 in regard to the number of cycles required to achieve conception. The use of a urinary LH immunoassay for insemination timing offers no benefit over conventional methods of timing (BBT, cervical mucus) when fresh donor semen is used.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>3286288</pmid><doi>10.1016/S0015-0282(16)59955-5</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0015-0282 |
ispartof | Fertility and sterility, 1988-06, Vol.49 (6), p.1026-1029 |
issn | 0015-0282 1556-5653 |
language | eng |
recordid | cdi_proquest_miscellaneous_78237440 |
source | MEDLINE; Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Adult Biological and medical sciences Birth control Body Temperature Cervix Mucus - analysis Female Fertility Gynecology. Andrology. Obstetrics Humans Immunoenzyme Techniques Insemination, Artificial Insemination, Artificial, Heterologous Luteinizing Hormone - urine Male Medical sciences Menstrual Cycle Ovulation Detection - instrumentation Ovulation Detection - methods Sterility. Assisted procreation Time Factors |
title | Therapeutic donor insemination: the impact of insemination timing with the aid of a urinary luteinizing hormone immunoassay |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T15%3A56%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20donor%20insemination:%20the%20impact%20of%20insemination%20timing%20with%20the%20aid%20of%20a%20urinary%20luteinizing%20hormone%20immunoassay&rft.jtitle=Fertility%20and%20sterility&rft.au=Kossoy,%20Liliana%20R.&rft.date=1988-06-01&rft.volume=49&rft.issue=6&rft.spage=1026&rft.epage=1029&rft.pages=1026-1029&rft.issn=0015-0282&rft.eissn=1556-5653&rft.coden=FESTAS&rft_id=info:doi/10.1016/S0015-0282(16)59955-5&rft_dat=%3Cproquest_cross%3E78237440%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78237440&rft_id=info:pmid/3286288&rft_els_id=S0015028216599555&rfr_iscdi=true |